[
    [
        {
            "time": "2018-03-21",
            "original_text": "U.S. District Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit",
            "features": {
                "keywords": [
                    "Court Rules",
                    "Lilly",
                    "Alimta",
                    "Patent Lawsuit"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "U.S. District Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-15",
            "original_text": "Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer",
            "features": {
                "keywords": [
                    "Lilly",
                    "Phase 3",
                    "Clinical Trial",
                    "RET-Mutant",
                    "Thyroid Cancer"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]